Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.66 USD +0.99 (+0.68%)
Official Closing Price Updated: 7:59 PM EDT, Sep 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Dow Jones Finishes Week With Strong Gains; This Leaderboard Stock Is In Buy Range
The Dow Jones Industrial Average posted strong gains in today's stock market, while the Nasdaq and S&P 500 ended the day higher. 
From Investor's Business Daily
How Top Stocks Like Netflix, Workday, Emergent BioSolutions Are Holding Up After Volatile Week
Find out how Netflix and other top stocks to watch on IBD's elite Sector Leaders list are holding up after a volatile week on Wall Street. 
From Investor's Business Daily
There are four coronavirus vaccines in late-stage studies; here’s how they differ
Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can... 
Tags BNTX PFE Medical Products
From MarketWatch
FDA to TikTok teens: the ‘Benadryl Challenge’ can kill you
The social media-fueled dare to overdose on the allergy medicine can cause death and serious health problems 
Tags PG General TWTR
From MarketWatch
Nasdaq Jumps Despite Costco Pullback; Novavax Starts Vaccine Phase 3 Trial
Investors went into the weekend on an optimistic note. 
Tags NVAX COST Market News
From Motley Fool
Dow Jones Comes Back From Early Dive; Apple, Microsoft Lead Tech Stock Rally
Key market indexes moved off session highs midday Friday, after the Dow Jones Industrial Average had swung from an 180-point loss to a 100-point gain. 
From Investor's Business Daily
Closing A Light Earnings Week
Recent earnings reports imply that the positive momentum from early July is still in the air. Last week, Adobe (NASDAQ: ADBE) and FedEx ... 
Tags JNJ THO Markets
From Benzinga
3 Dividend Aristocrats to Buy and Hold Forever
Common denominators for these three stocks include great dividend records and solid businesses. 
Tags Market News JNJ ORCL
From Motley Fool
Tesla Doesn't Belong In This Group
This past decade has seen exceptional growth in the United States stock market. With any growth period, there are always companies that get caught up in the hype. It seems that Tesla is one of those... 
Tags Stocks / Equities Capital & Industrial Goods
From Blogs - TalkMarkets
Moderna Analyst On 4 Coronavirus Vaccine Program Risks
Moderna Inc (NASDAQ: MRNA) is one of the frontrunners in a crowded race to develop a vaccine against the novel coronavirus. Despite ... 
Tags Mani Foroohar Price Target Reiteration
From Benzinga
Current Updates On COVID-19 Vaccine
Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity ... 
Tags Market News MRNA CASBF
From Benzinga
Top Biotech Stocks To Watch Before Friday; 3 Names To Know
From Stockmarket.com
Dow Jones Today Futures Mixed; Tesla Drags On Nasdaq: Jefferies Financial, Owens & Minor Spike
Stock futures were mixed Thursday as Jefferies Financial spiked, Tesla dragged on the Nasdaq, and the Dow Jones today faced a test of support. 
From Investor's Business Daily
3 Stocks to Buy Ahead of the Next Market Crash
These big pharma companies are surviving the pandemic, and their solid dividends and consistent growth should help them do well in the next recession. 
Tags ABBV LLY JNJ
From Motley Fool
Top 3 Dividend Stocks You'll Want to Own Forever
These companies can serve as a solid foundation for a long-term portfolio. 
Tags MDT CVS JNJ
From Motley Fool
18 ETFs That Could Help You Send Your Kids to College
Here are a bunch of exchange-traded funds with above-average growth rates. See which ones most inspire your confidence. 
Tags AVGO INTC GOOG
From Motley Fool
For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?
Despite constant legal fights, this dividend aristocrat is one of the most admired companies in America -- for now. 
Tags Market News JNJ GE
From Motley Fool
J&J In Final Stage COVID-19 Tests: Would You Take the Vaccine?
Johnson & Johnson (JNJ​​​​​​​) starts a 60,000 person phase-3 trial test. Stage-3 is the final phase. 
Tags Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Asian stocks mostly lower early Thursday amid declining confidence in U.S. economy and escalating political turmoil
Asian shares were mostly lower Thursday as caution set in after a retreat on Wall Street driven by a decline in technology shares. 
Tags Mining and Metals AU:XJO USDJPY
From MarketWatch
Gilead Settles US Kickback Allegations For $97M
Gilead Sciences, Inc (NASDAQ: GILD) has agreed to pay $97 million to settle allegations that it illegally paid for Medicare co-pays for ... 
Tags Biotech UTHR JNJ
From Benzinga
Trump says Kentucky attorney general is ‘handling’ Breonna Taylor situation ‘very well’ and refuses to commit to peaceful transition of power
Tags JNJ
From MarketWatch
September Sell-Off: S&P 500 Craters 78 Points, Approaching Correction Levels as Apple, Oxy, Lead Tech Stocks, Energy Stocks Down
Almost 480 of the S&P's component stocks lost value today, and every sector finished the day lower as the index closed on the cusp of a correction. 
Tags XLK Market News OXY
From Motley Fool
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway. 
Tags BNTX PFE AZN
From Motley Fool
Cramer Reacts To Johnson & Johnson's Coronavirus Vaccine Update: 'Not A Hype Company'
Global health care giant Johnson & Johnson (NYSE: JNJ) is proceeding with a Phase 3 trial of its coronavirus vaccine, and it ... 
Tags Market News FDA Jim Cramer
From Benzinga
Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles
The number of deaths in the U.S. as a result of the coronavirus that causes COVID-19 surged past the 200,000 mark, while the global count climbed closer to 1 million, while Johnson & Johnson provided a... 
Tags Health/Care UK:AZN JNJ
From MarketWatch
Dow Jones Red Despite Big Nike Rally; Nasdaq Drops As Tech Stocks Sell Off
Stocks were broadly lower in afternoon trading Wednesday, as the Dow Jones Industrial Average remained underwater after giving up an early gain. 
From Investor's Business Daily
Why Vaxart Stock Is Retreating Today
Johnson & Johnson's rapid progress on its coronavirus vaccine is weighing on the biotech's shares today. 
Tags Market News JNJ VXRT
From Motley Fool
Just 4 in 10 Americans now say they would get a first-generation coronavirus vaccine — and most don’t expect to pay out of pocket
Seven vaccine candidates in the U.S. are in the clinical-trial phase with human participants. 
Tags BNTX PFE AZN
From MarketWatch
Why Genmab's Stock Is Trading Lower Today
Genmab (NASDAQ: GMAB) shares are trading lower on Wednesday after the company announced legal arbitration with partner Johnson & ... 
Tags Benzinga GMAB Market News
From Benzinga
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
Johnson & Johnson has joined the big league of frontrunners in the coronavirus vaccine race following its announcement concerning the initiation of the Phase 3 study. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.